| Document |
Document Title |
|
WO/2013/119542A1 |
The disclosure provides compounds of formula (I), including pharmaceutically acceptable salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in t...
|
|
WO/2013/102431A1 |
Provided are compounds useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound described herein.
|
|
WO/2013/094618A1 |
A liquid crystal aligning agent which contains a compound represented by formula [1] and at least one kind of polymer that is selected from among polyimide precursors and polyimides. (In formula [1], R1 represents a hydrogen atom or a me...
|
|
WO/2013/091474A1 |
The present invention provides a water-soluble sulfur dye having carboxyl groups. For the kind of dye, a sulfur dye is first reduced to a leuco compound by sodium sulfide, and the leuco compound reacts with an active compound containing ...
|
|
WO/2013/087643A1 |
The present invention relates to compounds corresponding to formula (I) in which: - R1 represents a substituted phenyl; - R2 represents: - a substituted phenyl; - a heteroaromatic group, the said group being unsubstituted or substituted ...
|
|
WO/2013/089212A1 |
The present invention provides a novel compound that has P2X3 and/or P2X2/3 receptor antagonist activity, for example, a compound represented by formula (I) or a pharmaceutically acceptable salt thereof. (In the formula, Ra and Rb as wel...
|
|
WO/2013/084013A1 |
The present invention relates to compounds of formula 1 that are useful as an active ingredient of a medicament for preventive and/or therapeutic treatment of diseases caused by abnormal activation of CXCR3 chemokines. The invention rela...
|
|
WO/2013/081064A1 |
Provided is a liquid crystal aligning agent which has good rubbing resistance and is capable of providing a liquid crystal alignment film that has high resistance to a process for aligning liquid crystals by the irradiation of ultraviole...
|
|
WO/2013/081552A1 |
Described herein is a melamine-aldehyde polymer, wherein the polymer has a pore volume in the range of about 1.5 to 5 cm3/g.
|
|
WO/2013/073681A1 |
[Problem] To provide: a hydroxy group protecting agent which is stable and easy to use, does not have carcinogenicity, a tearing property or the like, and is inexpensive; and a hydroxy group protection method which enables the protection...
|
|
WO/2013/070385A1 |
Methods for making asymmetrical triazines are provided. The methods comprise first forming a mixture of at least two primary amines then reacting the mixture with an aldehyde. Methods for removing sulfides from hydrocarbon streams are al...
|
|
WO/2013/068551A1 |
The present invention relates to novel compounds (I) containing two disubstituted triazine rings covalently linked by an organic linker, thereby creating dimers. These compounds show activity against the causative infective agents of inf...
|
|
WO/2013/064946A1 |
The present invention relates to whitening compositions, processes for obtaining such compositions, stable aqueous solutions of such compositions and the use of such compositions for whitening of textile fibers, paper and in detergency.
|
|
WO/2013/066078A1 |
The present invention relates to an alkoxysilyl-based isocyanurate epoxy compound, a method of preparing same, a composition including same, a cured product of the composition and a use of the composition. A complex including the compoun...
|
|
WO/2013/059735A1 |
Pharmaceutical preparations, compositions, systems, and devices including medical devices and diagnostic or therapeutic agents, and methods to treat disease by modification of local tissue environment to modulate the therapeutic index of...
|
|
WO/2013/047412A1 |
Provided is a novel triazine compound which has an improved ultraviolet shielding effect, light resistance, and heat resistance to be used as an ultraviolet absorber. The compound of the present invention is expressed by the following fo...
|
|
WO/2013/040622A1 |
The invention relates to the use of a compound of the following formula (I), for triggering the differentiation of mammalian cells from cardiomyocyte-like cells, the X being, independently, -NR4- or -O-, R4 being hydrogen or C1-6-alkyl; ...
|
|
WO/2013/041652A1 |
The invention relates to compounds of formula (I), wherein m, n, R 1, T 0 and T 1 have the meaning as cited in the description and the claims. Said compounds are useful as inhibitors of mTOR for the treatment or prophylaxis of mTOR relat...
|
|
WO/2013/041592A1 |
Use of one or more amino-triazine based Mannich-compounds and/or their dimers or trimers and/or one or more precondensate therefrom, including special new amino-triazine based Mannich-compounds, as antioxidant and/or UV-stabilizer for or...
|
|
WO/2013/024820A1 |
Disclosed are a polyimide precursor for obtaining a polyimide film having excellent adhesiveness with respect to metals and improved transmissivity in the UV-visible range, a polyimide in which the polyimide precursor is used, a polyimid...
|
|
WO/2013/018012A1 |
The present invention relates to a composition comprising a fluorescent whitening agent and a tertiary alkanolamine, a stable aqueous solution of such a composition and use of such composition for the bleaching of textile fibres or paper.
|
|
WO/2013/006092A1 |
The invention relates to organic chemistry, specifically to an improved method for preparing melamine cyanurate, which is used in various compositions as a fire retardant. When reacting cyanuric acid and melamine in a molar ratio in the ...
|
|
WO/2012/171876A1 |
The invention relates to the use of a composition for optically whitening paper or board, wherein the composition comprises specific sulfo-type bis-triazinylamino-stilbene compounds.
|
|
WO/2012/159557A1 |
The present invention relates to a substituted triazine phenylurea derivative and a use thereof as an inhibitor of protein kinases, especially Raf-1, and the compound of the present invention is useful in treatment of various disorders a...
|
|
WO/2012/160034A1 |
The present invention relates to 4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group of general formula (I) or (Ia) as described and defined herein, and methods for their preparation, their use for the treatment and/or ...
|
|
WO/2012/146353A1 |
The instant invention relates to novel water soluble bis-(triazinylamino)-stilbene optical brightening agents, a process for their preparation and their use for whitening natural and synthetic materials.
|
|
WO/2012/146056A1 |
Provided in the present invention is a system for producing melamine by means of gas quenching and a process thereof, the system comprising: a urea scrubber, and a fluidized bed reactor, a hot gas cooler, a hot gas filter, a crystallizer...
|
|
WO/2012/147896A1 |
A novel organometallic complex which can emit phosphorescence is provided. A light-emitting element, a light-emitting device, an electronic device, or a lighting device with high emission efficiency is provided. The organometallic comple...
|
|
WO/2012/143399A1 |
The present invention relates to substituted 4-Aryl-N-phenyl-1,3,5-triazin-2-amines of general formula (I) as described and defined herein, and methods for their preparation, their use for the treatment and/or prophylaxis of disorders, i...
|
|
WO/2012/142642A1 |
The invention relates to melamine thiosulfate or bis(2,4,6-triamino-1,3,5-triazinium)thiosulfate, to methods for producing the same and to the use thereof as flame retardant, particularly as a synergist for known flame retardants.
|
|
WO/2012/142329A1 |
The invention relates to compounds, pharmaceutical compositions and medicaments comprising such compounds, and the use of these compounds, compositions, and medicaments in methods of treating diseases and disorders.
|
|
WO/2012/136873A2 |
The invention relates to compounds derived from triazine, which can block the activity of TRPV1, and to the therapeutic uses thereof. More specifically, the applicants have synthesised trisubstituted triazines which can specifically inhi...
|
|
WO/2012/130827A1 |
The invention relates to a process for the purification of a melamine condensation product, comprising the steps of a) making a diluted slurry of a reaction product mixture comprising the melamine condensation product in a solution of a ...
|
|
WO/2012/126628A1 |
The invention relates to a composition suitable for optically whitening paper or board, wherein the composition contains specified bis- triazinylamino-stilbene fluorescent whitening agents with carboxylic acid and/or sulfonic acid groups...
|
|
WO/2012/127425A1 |
A process is described for the preparation of s-triazine derivatives of the formula in which R is a C1-C12-alkyl radical, by reacting a cyanuric acid halide with a p-aminobenzoic acid ester, which comprises a C6-C12-alkyl radical as radi...
|
|
WO/2012/126948A1 |
The present invention relates to a stabilizer composition for halogen-containing polymers and polymer mixtures, comprising at least one metal salt of isocyanuric acid, isothiocyanuric acid or a derivative thereof, to a process for the pr...
|
|
WO/2012/122891A1 |
Disclosed in the present invention is an oxime-containing amino derivative, and the pharmaceutical composition, preparation method and use thereof. In particular, the oxime-containing amino derivative is as shown in formulae Ⅰ or Ⅱ, ...
|
|
WO/2012/123870A1 |
Condensation products of melamine and phenylphophonic acid, a process for their preparation, their compositions with polymeric materials and their use as flame retardants in polymer substrates are provided. The compositions are especiall...
|
|
WO/2012/117048A1 |
The present invention relates to disubstituted triazine derivatives and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of infe...
|
|
WO/2012/115575A1 |
The present invention relates to a compound for use as a medicament, especially for treating bone, tooth and cartilage related diseases and damages. The compound has shown to be inducing and enhancing osteogenic differentiation. The pres...
|
|
WO/2012/072663A9 |
The present invention relates to a new process of separation of triazine derivatives enantiomers involving tartaric acid.
|
|
WO/2012/112530A2 |
There is provided an electroactive composition including (a) a host, (b) a dopant, and (c) an additive having Formula I, In Formula I, E is the same or different at each occurrence and is N or C-Ar1 and Ar1 is the same or different at ea...
|
|
WO/2012/107163A1 |
The invention relates to materials, to electroluminescence devices comprising said materials and to the use thereof.
|
|
WO/2012/027625A9 |
The invention provides a novel class of scaffold-based labeled polymerase enzyme substrates. The polymerase enzyme substrates have a multivalent core or scaffold to which is attached fluorescent dye moieties and nucleoside phosphate moit...
|
|
WO/2012/099059A1 |
The purpose of the present invention is to provide: a water-soluble yellow pigment (compound) exerting high water solubility and coloring properties, and exhibiting excellent color saturation on recorded images; and a yellow ink composit...
|
|
WO/2012/099057A1 |
The purpose of the present invention is to provide: a water-soluble yellow pigment (compound) exerting high water solubility and coloring properties, and exhibiting excellent color saturation on recorded images; and a yellow ink composit...
|
|
WO/2012/090933A1 |
The purpose of the present invention is to provide: a water-soluble yellow colorant (compound) which is highly soluble in water, has high color-developing properties, and gives recorded images having an excellent chroma; and a yellow ink...
|
|
WO/2012/087960A1 |
There is provided a compound having at least one unit of Formula I (Formula I should be inserted here) where Ar1, Ar2, and Ar3 are the same or different and have Formula II (Formular II should be inserted here) In Formula II: R1 is the s...
|
|
WO/2012/079678A1 |
The invention relates to substances, to electroluminescent devices containing said substances and to the use thereof.
|
|
WO/2012/073902A1 |
The purpose of the present invention is to provide a polymer compound which is capable of providing high luminous efficiency and enables a light emitting element to achieve excellent luminance stability even in cases where the light emit...
|
